Nautilus Biotechnology, Inc. (NAUT): who owns it and who trades it
As of Nov 12, 2026, NAUT insiders reported 2 open-market sales worth $11.8M and 1 purchase worth $65.2K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was AH Bio Fund II, L.P. (10% owner), with $11.8M. 1 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 12, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Nautilus Biotechnology
From the latest filingsOverall: more buying than selling. Insiders mostly sold. Funds and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns NAUT
93 funds and institutions reported NAUT shares worth $93.9M at the end of Q2 2026, about 40% of the company. The largest holder is Perceptive Advisors LLC with 9.2%.
Funds and institutions (13F) 40%Everyone else 60%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Perceptive Advisors LLC | 11.63M | 9.16% | $21.8M | -8% |
| A16z Capital Management, L.L.C. | 9.06M | 7.13% | $16.9M | -49% |
| Cercano Management LLC | 7.17M | 5.64% | $13.4M | No change |
| BlackRock, Inc. | 2.69M | 2.11% | $5M | +1332% |
| Vanguard Capital Management LLC | 2.55M | 2.01% | $4.8M | +0% |
| Comprehensive Financial Management LLC | 2.21M | 1.74% | $4.1M | No change |
| Citadel Advisors LLC | 1.90M | 1.49% | $3.5M | New |
| Geode Capital Management, LLC | 1.27M | 1.00% | $2.4M | +110% |
| Acadian Asset Management LLC | 1.06M | 0.83% | $2M | +42% |
| Clearstead Advisors, LLC | 892,787 | 0.70% | $1.7M | -62% |
| Susquehanna International Group, LLP | 890,949 | 0.70% | $1.7M | New |
| Sentinel Trust Co Lba | 750,000 | 0.59% | $1.4M | No change |
| Barclays PLC | 725,321 | 0.57% | $1.4M | +889% |
| Renaissance Technologies LLC | 690,514 | 0.54% | $1.3M | +160% |
| JPMorgan Chase & Co | 614,177 | 0.48% | $1.1M | New |
| State Street Corp | 559,508 | 0.44% | $1M | +159% |
| Dimensional Fund Advisors LP | 475,844 | 0.37% | $889K | +45% |
| Northern Trust Corp | 381,234 | 0.30% | $713K | +256% |
| Hrt Financial LP | 361,073 | 0.28% | $675K | +453% |
| Vanguard Fiduciary Trust Co | 353,093 | 0.28% | $660K | +16% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, NAUT insiders reported $65.2K of open-market purchases and $11.8M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | AH Bio Fund II, L.P. +5 | 10% owner | Sale | 4.62M | $2.35 | $10.8M | Form 4 |
| Jun 2, 2026 | AH Bio Fund II, L.P. +5 | 10% owner | Sale | 384,026 | $2.35 | $902K | Form 4 |
| Mar 4, 2026 | Sujal M Patel | CEO | Purchase | 25,000 | $2.61 | $65.2K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| AH Bio Fund II, L.P. | 10% owner | – | $11.8M | Jun 2, 2026 |
| Sujal M Patel | CEO, President, and Secretary, Director, 10% owner | $65.2K | – | Mar 4, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
NAUT short interest
Low short interest. 4.6% of NAUT shares are sold short: about 1 share in 22. Over the last 12 reports the number of shares short went up 608%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 5.84M NAUT shares were sold short, 4.6% of the shares outstanding, up 3.9% from the report before. At the average daily volume of 11.59M shares, buying them all back would take about 1.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 5.84M | 4.58% | +4% | 11.59M | 1.0 |
| Oct 15, 2026 | 5.62M | 4.42% | -3% | 12.60M | 1.0 |
| Sep 30, 2026 | 5.77M | 4.54% | +41% | 4.07M | 1.4 |
| Sep 15, 2026 | 4.08M | 3.21% | +7% | 1.26M | 3.2 |
| Aug 31, 2026 | 3.81M | 3.00% | +21% | 591,904 | 6.4 |
| Aug 14, 2026 | 3.15M | 2.48% | +39% | 859,562 | 3.7 |
| Jul 31, 2026 | 2.27M | 1.79% | +57% | 835,918 | 2.7 |
| Jul 15, 2026 | 1.45M | 1.14% | +75% | 1.11M | 1.3 |
| Jun 30, 2026 | 829,522 | 0.65% | +53% | 1.33M | 1.0 |
| Jun 15, 2026 | 541,139 | 0.43% | -29% | 407,837 | 1.3 |
| May 29, 2026 | 760,157 | 0.60% | -8% | 432,665 | 1.8 |
| May 15, 2026 | 825,026 | 0.65% | +15% | 390,865 | 2.1 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Nautilus Biotechnology company events
Nautilus Biotechnology filed 6 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Oct 27, 2026.
- Oct 27, 2026ResultsReleased financial results. Filing
- Sep 11, 2026AgreementNautilus Biotechnology, Inc. entered into a Sales Agreement with TD Securities (USA), LLC to sell shares of the Company’s common stock, par value $0.0001 per share, having aggregate sales proceeds of up to $125 million, from time to time, through an “at the market” offering program under which TD… Filing
- Jul 28, 2026ResultsReleased financial results. Filing
- Jun 18, 2026VoteReported shareholder vote results. Filing
- Apr 28, 2026ResultsReleased financial results. Filing
- Feb 26, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Nautilus Biotechnology financials
Famous investors that hold NAUT
1 of the 50 well-known investors we track reported holding NAUT in their latest 13F filing. The largest position is Jim Simons's, worth $2.3M.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 1.62M | $2.3M | 0.0% | +134% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named NAUT in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 3, 2026 | Perceptive Advisors LLC | 13D/A | 3.9% |
| Nov 3, 2026 | Perceptive Advisors LLC | 13D/A | 3.9% |
Questions about Nautilus Biotechnology, Inc. (NAUT) stock
Who owns the most NAUT stock?
The largest reported owner of Nautilus Biotechnology, Inc. (NAUT) is Perceptive Advisors LLC, with 9.2% of the company. In total, 93 funds and institutions reported holding NAUT at the end of Q2 2026, together about 40% of the shares. See the largest owners.
Are NAUT insiders buying or selling?
In the last 12 months, NAUT insiders reported 1 open-market purchase worth $65.2K and 2 sales worth $11.8M. The latest trade was on Jun 2, 2026. See every trade.
What is the short interest in NAUT?
As of Oct 30, 2026, 5.84M NAUT shares were sold short, 4.6% of the shares outstanding, up 3.9% from the report before. At the average daily volume of 11.59M shares, buying them all back would take about 1.0 trading days (days to cover). See the history.
Which famous investors hold NAUT?
1 of the 50 well-known investors we track reported NAUT in their latest 13F filing, including Jim Simons. The largest position is worth $2.3M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.